A SUNDERLAND chemistry business is hoping to grow Stateside after appointing a new business development director based in Chicago.
Onyx Scientific has appointed Dan Brisard to oversee the contract manufacturing organisation’s business development activities across the eastern half of the US.
An experienced commercial executive, Brisard has worked across the pharmaceutical manufacturing sector for around 15 years.
A graduate in Chemistry from the University of Illinois and in Analytical Chemistry from the Illinois Institute of Technology, he brings technical knowhow to his new role that will assist the company’s US-based pharmaceutical and biotechnology clients. Denise Bowser, commercial director at Onyx Scientific, said: “Having Dan on board is a massive boost to the company as he brings exceptional commercial experience gained in the industry along with a strong chemistry background.
“At the request of our customers, we have really looked to expand our offering over the last year to minimise the need for clients to use several suppliers on the same project.
“Dan will play a key role in communicating the breadth of our services in addition to our track record and achievements to the US market.”
With licensed facilities in the UK and India, Onyx Scientific assists companies developing new drugs from initial chemistry work right through to large-scale commercial manufacturing.
Brisard said: “I have been really impressed with Onyx Scientific over the last few years and was attracted by the company’s strong reputation in the contract chemistry and manufacturing sector. The team is very experienced and we have serious chemistry capabilities to offer the drug development market. I look forward to working with my new colleagues to help the company meet its commercial ambitions and increase market share in the US.”
Onyx Scientific has expanded its services to the global pharmaceutical market by striking alliances other UK companies including Reach Separations and Molecular Profiles.